145 related articles for article (PubMed ID: 36043408)
21. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K
Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875
[TBL] [Abstract][Full Text] [Related]
22. MiR-106a aggravates sepsis-induced acute kidney injury by targeting THBS2 in mice model.
Shen Y; Yu J; Jing Y; Zhang J
Acta Cir Bras; 2019 Aug; 34(6):e201900602. PubMed ID: 31432993
[TBL] [Abstract][Full Text] [Related]
23. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Waschbisch A; Atiya M; Linker RA; Potapov S; Schwab S; Derfuss T
PLoS One; 2011; 6(9):e24604. PubMed ID: 21949733
[TBL] [Abstract][Full Text] [Related]
24. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
[TBL] [Abstract][Full Text] [Related]
25. miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.
Ehtesham N; Khorvash F; Kheirollahi M
J Mol Neurosci; 2017 Jan; 61(1):16-24. PubMed ID: 27752929
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-106a Provides Negative Feedback Regulation in Lipopolysaccharide-Induced Inflammation by targeting TLR4.
Yang J; Chen Y; Jiang K; Yang Y; Zhao G; Guo S; Deng G
Int J Biol Sci; 2019; 15(11):2308-2319. PubMed ID: 31595149
[TBL] [Abstract][Full Text] [Related]
27. Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.
Gong Q; Xie J; Li Y; Liu Y; Su G
J Cell Mol Med; 2019 Jul; 23(7):4723-4737. PubMed ID: 31094072
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
29. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
30. The expression and prognostic value of miR-146a and miR-155 in Turkish patients with multiple sclerosis.
Saridas F; Tezcan Unlu H; Cecener G; Egeli U; Sabour Takanlou M; Sabour Takanlou L; Tunca B; Zarifoglu M; Turan OF; Taskapilioglu O
Neurol Res; 2022 Mar; 44(3):217-223. PubMed ID: 34503396
[TBL] [Abstract][Full Text] [Related]
31. Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis.
Fattahi M; Eskandari N; Sotoodehnejadnematalahi F; Shaygannejad V; Kazemi M
Cell J; 2020 Apr; 22(1):92-95. PubMed ID: 31606972
[TBL] [Abstract][Full Text] [Related]
32. Expression levels of IL-17/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis.
Balkan E; Bilge N
Neurol Res; 2021 Sep; 43(9):778-783. PubMed ID: 34130607
[No Abstract] [Full Text] [Related]
33. miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.
Elkhodiry AA; Zamzam DA; El Tayebi HM
Mult Scler Relat Disord; 2021 Aug; 53():103078. PubMed ID: 34171684
[TBL] [Abstract][Full Text] [Related]
34. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α.
Zhu D; Pan C; Li L; Bian Z; Lv Z; Shi L; Zhang J; Li D; Gu H; Zhang CY; Liu Y; Zen K
J Allergy Clin Immunol; 2013 Aug; 132(2):426-36.e8. PubMed ID: 23562609
[TBL] [Abstract][Full Text] [Related]
36. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
Ding H; Hu CX; Xu JK
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic protease activating factor-1 gene and MicroRNA-484: A possible interplay in relapsing remitting multiple sclerosis.
Mohamed DAW; Selim HM; Elmazny A; Genena A; Nabil MM
Mult Scler Relat Disord; 2022 Feb; 58():103502. PubMed ID: 35030371
[TBL] [Abstract][Full Text] [Related]
40. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis.
Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM
Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
